Catalent Expands Biologics Packaging Capacity

Published on: 

Catalent Biologics increased capacity at its Bloomington, IN Facility.

Catalent announced in an April 23, 2020 press release that it completed its $14 million expansion to increase the biologics packaging capabilities and capacity at its Bloomington, IN facility. The company added 15,000-ftof packaging infrastructure to the existing biologics and sterile manufacturing site, including five new packaging suites and a new quality control laboratory.

Three new packaging lines include an Optima combination syringe assembly machine, an automated Mikron auto-injector assembly machine, and a Dividella NeoTOP x (NTX) top-load cartoner with both semi-automated and fully-automated configurations. All three high-speed lines are fully qualified and ready to provide customers faster and more flexible packaging solutions for vials, syringes, and devices with no glass-to-glass contact.

“The completion of this expansion marks a major milestone for our late-stage and commercial customers, allowing Catalent to focus on more complex device assembly and packaging needs for biologic products at higher volumes,” commented Mike Riley, region president, Biologics North America, in the press release. “This state-of-the-art equipment adds to our growing network of global packaging capabilities alongside our Brussels, Belgium, and Anagni, Italy drug product manufacturing sites.”


Source: Catalent